Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid

scientific article

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1042711082
P356DOI10.1007/S11894-999-0085-4
P8608Fatcat IDrelease_p2fzrpt3rvfnnav7yet2665js4
P698PubMed publication ID10980925

P2093author name stringLee YM
Kaplan MM
P2860cites workA multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisQ40883127
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.Q44951192
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosisQ49110706
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosisQ51586165
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.Q51597193
Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.Q54072767
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.Q54118475
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trialQ68019501
Ursodeoxycholic acid for primary sclerosing cholangitisQ68095108
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acidQ68925952
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosisQ71035932
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisQ72401649
Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodQ72503309
Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study GroupQ73090826
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective studyQ73167014
P433issue1
P921main subjectascending cholangitisQ603644
primary sclerosing cholangitisQ1058608
primary biliary cholangitisQ1072420
sclerosing cholangitisQ18554727
P304page(s)38-41
P577publication date1999-02-01
P1433published inCurrent gastroenterology reportsQ26842032
P1476titleTreatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid
P478volume1

Reverse relations

cites work (P2860)
Q34687676Drug therapy of primary biliary diseases: classical and modern strategies.
Q34936778Evolving new therapies of autoimmune hepatitis
Q34515652Primary biliary cirrhosis: new thoughts on pathophysiology and treatment
Q44451209Sclerosing cholangitis as a complication of Langerhans'cell histiocytosis
Q41701715Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report

Search more.